Hey I am on Medial • 4m
Let's be real - Molbio's revenue chart is essentially a COVID bubble, not a sustainable growth story. Yes, they went from 51Cr to 1,272Cr, but then immediately fell back to 332Cr post-pandemic. That's a 74% revenue DROP in just two years. Their projected 1,200Cr for FY25 sounds suspiciously convenient for IPO timing - I'd be extremely skeptical of those projections. The valuation of 22,000-24,000Cr is about 20x their projected revenue, which is absurdly high for a biotech hardware company with this much volatility. For comparison, traditional medtech companies trade at 3-5x revenue. This has all the hallmarks of trying to cash in before the growth story falls apart. I'm staying far away from this one.
In God We Trust, The... • 1m
How 3 cousins from Punjab turned a ₹10 desi drink into a ₹300 Cr empire 💥" In 2017, 3 cousins from Fatehgarh, Punjab sat down with a goal: 🗣️ “Let’s make India drink its own taste again.” While MNCs pushed sugary colas, they bottled up: Zeera
See More•
OpenAI • 7m
Launched in late 2024, Jarvis is that cool new kid on the block that's shaking up advertising for brands selling on Zepto. Imagine a tool so smart that it's already blasted out 15 billion ad impressions and has generated advertising revenue equivalen
See MoreDownload the medial app to read full posts, comements and news.